HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis.

AbstractAIM:
To evaluate the incidence of contrast-induced nephropathy (CIN) in cirrhotic patients and to identify risk factors for the development of CIN.
METHODS:
We performed a retrospective review of 216 consecutive patients with cirrhosis who underwent computed tomography (CT) with intravenous contrast at the University of Rochester between the years 2000-2005. We retrospectively examined factors associated with a high risk for CIN, defined as a decrease in creatinine clearance of 25% or greater within one week after receiving contrast.
RESULTS:
Twenty-five percent of our patients developed CIN, and 74% of these patients had ascites seen on CT. Of the 75% of patients who did not develop CIN, only 46% had ascites. The presence of ascites was a significant risk factor for the development of CIN (P = 0.0009, OR 3.38, 95% CI 1.55-7.34) in multivariate analysis. Patient age, serum sodium, Model for End-stage Liver Disease score, diuretic use, and the presence of diabetes were not found to be significant risk factors for the development of CIN. Of the patients who developed CIN, 11% developed chronic renal insufficiency, defined as a creatinine clearance less than baseline for 6 wk.
CONCLUSION:
Our results suggest that in hospitalized cirrhotic patients, especially those with ascites, the risk of CIN is substantial.
AuthorsNilesh Lodhia, Michael Kader, Thalia Mayes, Parvez Mantry, Benedict Maliakkal
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 15 Issue 12 Pg. 1459-64 (Mar 28 2009) ISSN: 2219-2840 [Electronic] United States
PMID19322918 (Publication Type: Journal Article)
Chemical References
  • Contrast Media
  • Diuretics
Topics
  • Aged
  • Ascites (epidemiology)
  • Contrast Media (toxicity)
  • Diuretics (therapeutic use)
  • Female
  • Humans
  • Incidence
  • Inpatients
  • Kidney Diseases (chemically induced, epidemiology)
  • Liver Cirrhosis (complications)
  • Male
  • Middle Aged
  • Racial Groups
  • Retrospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: